Keywords: fda, clears, crestor, labelling, revision, anglo-swedish, drugmaker
FDA clears Crestor's labelling revision
Article | 07 March 2005
Anglo-Swedish drugmaker AstraZeneca says that the US Food and Drug Administration has approved a label change for its cholesterol-lowering Crestor ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
